Undisclosed Inhalation Chemotherapy

About Quench Medical

Quench Medical is tackling the significant unmet need in treating lung diseases, particularly lung cancer, by developing a targeted inhalation drug delivery platform. Its core technology is designed to overcome the lung's natural defenses and the limitations of current systemic and inhaled therapies, enabling high local drug concentrations in the lungs with lower systemic exposure. Led by a founder with a physics and medical device background and supported by an experienced executive team, the company has raised seed funding to advance its pipeline. Quench aims to improve patient outcomes by enhancing the therapeutic index of existing and novel drugs through direct pulmonary administration.

Therapeutic Areas

Other Lung Cancer Drugs